S 1681 · 116th Congress 2019–2021, ended

Advancing Education on Biosimilars Act of 2020

Fact sheet

Latest action · Dec 18, 2020 Held at the desk.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 23, 2019
  2. Passed SenateDec 17, 2020
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Advancing Education on Biosimilars Act of 2020

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)

The FDA may also maintain and operate a website to provide educational materials about biological products.

Cosponsors 1

Members who signed on, in the order they did. All signed on May 23, 2019.

SeatCosponsorSigned on
D-NHMargaret Wood HassanOriginalMay 23, 2019

Actions 9

Everything that happened, newest first.

  1. Dec 18, 2020Held at the desk.
  2. Dec 18, 2020Message on Senate action sent to the House.
  3. Dec 18, 2020Received in the House.
  4. Dec 17, 2020Measure laid before Senate by unanimous consent. (consideration: CR S7642-7643)
  5. Dec 17, 2020Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7643)

Amendments 1

Amendments offered to this bill.

AmendmentDescriptionOffered byStatus
SA 2716In the nature of a substitute.Lamar Alexander R-TNAmendment SA 2716 agreed to in Senate by Unanimous Consent.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 2

Each version as it was printed, newest first.

  1. Dec 17, 2020Engrossed in Senate
  2. May 23, 2019Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.